Industry reports
Editor highlights

Search inside this page

All regions

Free Market Research Guides to Download

Pathology Industry: Market Research Reports, Statistics and Analysis

  • Currently 5/5 Stars.
  • 1
  • 2
  • 3
  • 4
  • 5
4 reviews

(Photo: Stock.xchng)

Global Pathology Industry

 

Pathology involves the study of the damaging impact of disease on cells and tissues and the way in which the body seeks to protect and repair itself. Pathology can be divided into two main branches, namely clinical and anatomic.

 

1) Clinical pathology involves the analysis of bodily fluids to diagnose disease through laboratory testing. Pathologists study aspects of disease such as its cause, the way in which it develops, how disease changes cells and the clinical manifestations of this change. Chemical pathology involves biochemical testing of any bodily fluid, most commonly plasma or serum. This segment incorporates endocrinology, which is the study of endocrine gland cells and the tissues that produce them, immunology, and pharmacology, the study of drugs. In the branch of cytogenics pathologists study cells, particularly chromosomes. Cytogenetics has been used to study conditions such as Down syndrome. The Global Down Syndrome Foundation estimates Federal research funding was at $22 million in 2010.

 

Medical microbiology involves the analysis of microorganisms such as parasites, bacteria and viruses. This discipline provides information on how pathogens invade a host and the way in which the body protects itself. This allows medical professionals to determine how to best facilitate the immune system’s natural defense to heal infection. Advances in the field have led to vaccination against diseases such as tuberculosis. The discipline of medical microbiology includes the study of HIV. The Henry J. Kaiser Family Foundation reports 2011 federal spending on HIV/AIDS activities amounts to more than $20 billion in the US and almost $7 billion globally. With the World Health Organization estimating over 33 million people living with HIV in 2009 and close to 2 million deaths from AIDS, governments are likely to continue investing in pathology research into the disease.

 

2) The other main branch of pathology apart from clinical pathology is anatomic pathology, which involves the diagnosis of disease through laboratory analysis of the body. Anatomic pathology includes such fields of study as cytopathology, forensic pathology and surgical pathology. Forensic pathologists carry out autopsies on bodies to determine cause of death, disease or injury. It is a common practice in legal and criminal procedures and is often used to determine the circumstances of a person’s death.

 

Cytopathology involves the cellular study of disease and includes the screening process known as a pap smear, which is used to test for early signs of cervical cancer. Surgical pathology involves the analysis of biopsies and surgical resections. The former consists of removing a sample from a patient to make a diagnosis based on small structures to determine the presence of a tumor, and whether it is benign or malignant, in the treatment of cancer. Biopsy analysis is carried out to diagnose and treat other diseases such as those stemming from infection and inflammation. A surgical resection involves removing a diseased organ from a patient to avoid its continued damage to the body or its spreading to healthy surrounding organs.

 

 

...
More »

You might be interested in: cancer, mental health, cardiovascular disease, more »

» View Public Reports

1-10 of about 6 100 reports

U.S. Pharmaceutical Industry Analysis

  • Industry report
  • April 2014
  • 129 pages

... Of work are implicated as important causes of hypertension, as well as cvd., E.G. Job strain 96 schnall pl et al. Why the workplace and cardiovascular disease. In: schnall pl, belkic kl, landsbergis pa ...

  • Industries: Pathology
  • Countries: United States

The Australian Pharmaceutical Business Brief

  • Industry report
  • April 2014
  • 8 pages
  • by Corporation

... To compare the expenditure of other chronic diseases, particularly chronic diseases that share many of the same risk factors such as ckd [14]. As a result, this investigation will determine and compare ...

  • Industries: Pathology
  • Countries: Australia

Pharmaceutical Sector in Denmark

  • Industry report
  • April 2014
  • 23 pages
  • by Intergovernmental Agency

... Standardised to the who european standard population although mortality rates for typ. Chronic diseases vary largely, eastern european countries show significant higher motality rates as compared to southern ...

  • Industries: Pathology
  • Countries: Europe, World, Denmark

U.S. Diabete Sector

  • Industry report
  • April 2014
  • 28 pages

... Or insulin, or conventional treatment the ominous octet defronzo r.; diabetes 2009 metformin ampk Glucagon signaling Insulin sensitizer sglt-2 inhibitor insulin insulin sensitizer source ...

  • Industries: Pathology
  • Countries: United States

The Australian Pharmaceutical Industry Brief

  • Industry report
  • March 2014
  • 18 pages
  • Industries: Pathology
  • Countries: Australia

Pharmaceutical Sector in New Zealand

  • Industry report
  • March 2014
  • 43 pages
  • Industries: Pathology
  • Countries: New Zealand

U.S. Prostate Cancer Sector

  • Industry report
  • March 2014
  • 40 pages

... And respiratory infections. The vitamin d-sensitive diseases that account for more than half of global mortality rates are cvd, cancer, respiratory infections, respiratory diseases, tuberculosis and diabetes ...

  • Industries: Pathology
  • Countries: United States

Pharmaceutical : Innovation and Technology Trends

  • Industry report
  • March 2014
  • 42 pages
  • Industries: Pathology

Pharmaceutical Sector in Canada

  • Industry report
  • March 2014
  • 31 pages

... T as ia & pac ific n. A frica & m iddl e ea st sub -sah aran afr ica e.Eu rop e & c. A sia w. E uro pe & u.S . The percent of people aged 40+ with no previous diagnosis of diabetes ...

  • Industries: Pathology
  • Countries: Canada

Pharmaceutical Sector Analysis in Sri Lanka

  • Industry report
  • March 2014
  • 93 pages
  • by Intergovernmental Agency
  • Industries: Pathology
  • Countries: Sri Lanka
Search in Pathology Industry (About 6 100 reports)

» Purchase Premium Reports (From $ 75 - $ 9 995)

About 5 600 reports
PharmaPoint: Type 2 Diabetes - Global Drug Forecast and Market Analysis to 2022 - Event-Driven Update

PharmaPoint: Type 2 Diabetes - Global Drug Forecast and Market Analysis to 2022 - Event-Driven Update

  • $ 9 995
  • Industry report
  • January 2014
  • by Global Data

PharmaPoint: Type 2 Diabetes - Global Drug Forecast and Market Analysis to 2022 - Event-Driven Update Summary The type 2 diabetes market is mature and crowded with inexpensive generics. Despite being marked ...

Hiv -- Kol Insight And Consensus Outlook Modules

February 2014 $ 8 056

Analytical Tool - Hematological Cancers

March 2014 $ 8 925

Pharmapoint: Schizophrenia - 5eu Drug Forecast And Mark ...

February 2014 $ 6 995

Drugs For Treating Systemic Lupus Erythematosus: Global ...

March 2014 $ 6 650

Neurostimulation: Technologies And Global Markets

March 2014 $ 6 650

Digital Pathology: Technologies And Global Markets

February 2014 $ 6 650

Opportunityanalyzer: Pancreatic Cancer - Opportunity An ...

March 2014 $ 5 995

Hepatitis C: Game Changing Regimens To Revolutionise Tr ...

April 2014 $ 5 619

Non-small Cell Lung Cancer: Game Changing Immunotherapi ...

March 2014 $ 5 369

» Read our Company Profiles

33 Companies

EDGAR Online Inc.

United States

Roche Holding AG

Switzerland

Johnson and Johnson

United States

AccessEd

Australia

ReportLinker is a professional search engine that provides an easy access to 1,2 million market research reports and industry statistics published by 200,000 authoritative sources.